Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease.

Kauwe JS, Bertelsen S, Mayo K, Cruchaga C, Abraham R, Hollingworth P, Harold D, Owen MJ, Williams J, Lovestone S, Morris JC, Goate AM; Alzheimer's Disease Neuroimaging Initiative.

Am J Med Genet B Neuropsychiatr Genet. 2010 Jun 5;153B(4):955-9. doi: 10.1002/ajmg.b.31053.

2.

Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease.

Robson KJ, Lehmann DJ, Wimhurst VL, Livesey KJ, Combrinck M, Merryweather-Clarke AT, Warden DR, Smith AD.

J Med Genet. 2004 Apr;41(4):261-5.

3.

Effects of hemochromatosis and transferrin gene mutations on iron dyshomeostasis, liver dysfunction and on the risk of Alzheimer's disease.

Giambattistelli F, Bucossi S, Salustri C, Panetta V, Mariani S, Siotto M, Ventriglia M, Vernieri F, Dell'acqua ML, Cassetta E, Rossini PM, Squitti R.

Neurobiol Aging. 2012 Aug;33(8):1633-41. doi: 10.1016/j.neurobiolaging.2011.03.005. Epub 2011 Apr 21.

PMID:
21514009
4.

Iron genes, iron load and risk of Alzheimer's disease.

Lehmann DJ, Worwood M, Ellis R, Wimhurst VL, Merryweather-Clarke AT, Warden DR, Smith AD, Robson KJ.

J Med Genet. 2006 Oct;43(10):e52.

5.

Analysis of the effect of aluminum in drinking water and transferrin C2 allele on Alzheimer's disease.

Rondeau V, Iron A, Letenneur L, Commenges D, Duchêne F, Arveiler B, Dartigues JF.

Eur J Neurol. 2006 Sep;13(9):1022-5.

6.

Transferrin gene polymorphism in Alzheimer's disease and dementia with Lewy bodies in humans.

Hussain RI, Ballard CG, Edwardson JA, Morris CM.

Neurosci Lett. 2002 Jan 4;317(1):13-6.

PMID:
11750985
7.

Association of transferrin C2 allele with late-onset Alzheimer's disease.

Namekata K, Imagawa M, Terashi A, Ohta S, Oyama F, Ihara Y.

Hum Genet. 1997 Dec;101(2):126-9.

PMID:
9402955
8.

Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project.

Lehmann DJ, Schuur M, Warden DR, Hammond N, Belbin O, Kölsch H, Lehmann MG, Wilcock GK, Brown K, Kehoe PG, Morris CM, Barker R, Coto E, Alvarez V, Deloukas P, Mateo I, Gwilliam R, Combarros O, Arias-Vásquez A, Aulchenko YS, Ikram MA, Breteler MM, van Duijn CM, Oulhaj A, Heun R, Cortina-Borja M, Morgan K, Robson K, Smith AD.

Neurobiol Aging. 2012 Jan;33(1):202.e1-13. doi: 10.1016/j.neurobiolaging.2010.07.018. Epub 2010 Sep 2.

PMID:
20817350
9.

The SIRT2 polymorphism rs10410544 and risk of Alzheimer's disease in two Caucasian case-control cohorts.

Polito L, Kehoe PG, Davin A, Benussi L, Ghidoni R, Binetti G, Quadri P, Lucca U, Tettamanti M, Clerici F, Bagnoli S, Galimberti D, Nacmias B, Sorbi S, Guaita A, Scarpini E, Mariani C, Forloni G, Albani D.

Alzheimers Dement. 2013 Jul;9(4):392-9. doi: 10.1016/j.jalz.2012.02.003. Epub 2012 May 30.

PMID:
22651940
10.

Interaction of the H63D mutation in the hemochromatosis gene with the apolipoprotein E epsilon 4 allele modulates age at onset of Alzheimer's disease.

Combarros O, García-Román M, Fontalba A, Fernández-Luna JL, Llorca J, Infante J, Berciano J.

Dement Geriatr Cogn Disord. 2003;15(3):151-4.

PMID:
12584430
11.

HFE variants, APOE and Alzheimer's disease: findings from the population-based Rotterdam study.

Alizadeh BZ, Njajou OT, Millán MR, Hofman A, Breteler MM, van Duijn CM.

Neurobiol Aging. 2009 Feb;30(2):330-2. Epub 2007 Jul 12.

PMID:
17628213
12.

Meta-analysis on the association between the TF gene rs1049296 and AD.

Wang Y, Xu S, Liu Z, Lai C, Xie Z, Zhao C, Wei Y, Bi JZ.

Can J Neurol Sci. 2013 Sep;40(5):691-7.

PMID:
23968943
13.

Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosis.

de Tayrac M, Roth MP, Jouanolle AM, Coppin H, le Gac G, Piperno A, Férec C, Pelucchi S, Scotet V, Bardou-Jacquet E, Ropert M, Bouvet R, Génin E, Mosser J, Deugnier Y.

J Hepatol. 2015 Mar;62(3):664-72. doi: 10.1016/j.jhep.2014.10.017. Epub 2014 Oct 18.

14.

Transferrin C2 variant does confer a risk for Alzheimer's disease in caucasians.

Zambenedetti P, De Bellis G, Biunno I, Musicco M, Zatta P.

J Alzheimers Dis. 2003 Dec;5(6):423-7.

PMID:
14757931
15.

Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels.

Benyamin B, McRae AF, Zhu G, Gordon S, Henders AK, Palotie A, Peltonen L, Martin NG, Montgomery GW, Whitfield JB, Visscher PM.

Am J Hum Genet. 2009 Jan;84(1):60-5. doi: 10.1016/j.ajhg.2008.11.011. Epub 2008 Dec 11.

16.

Association study between late-onset Alzheimer's disease and the transferrin gene polymorphisms in Chinese.

Zhang P, Yang Z, Zhang C, Lu Z, Shi X, Zheng W, Wan C, Zhang D, Zheng C, Li S, Jin F, Wang L.

Neurosci Lett. 2003 Oct 9;349(3):209-11.

PMID:
12951205
17.

Effects of hemochromatosis and transferrin gene mutations on peripheral iron dyshomeostasis in mild cognitive impairment and Alzheimer's and Parkinson's diseases.

Mariani S, Ventriglia M, Simonelli I, Spalletta G, Bucossi S, Siotto M, Assogna F, Melgari JM, Vernieri F, Squitti R.

Front Aging Neurosci. 2013 Aug 5;5:37. doi: 10.3389/fnagi.2013.00037. eCollection 2013.

18.

Genes related to iron metabolism and susceptibility to Alzheimer's disease in Basque population.

Blázquez L, De Juan D, Ruiz-Martínez J, Emparanza JI, Sáenz A, Otaegui D, Sistiaga A, Martínez-Lage P, Lamet I, Samaranch L, Buiza C, Etxeberria I, Arriola E, Cuadrado E, Urdaneta E, Yanguas J, López de Munain A.

Neurobiol Aging. 2007 Dec;28(12):1941-3. Epub 2006 Oct 2.

PMID:
17011669
19.

[Apolipoprotein E genotype as a risk factor in Japanese patients with early-onset and late-onset Alzheimer's disease].

Shimada K, Yasuda M, Maeda K.

Seishin Shinkeigaku Zasshi. 1997;99(8):575-87. Japanese.

PMID:
9369084
20.

Variants in iron metabolism genes predict higher blood lead levels in young children.

Hopkins MR, Ettinger AS, Hernández-Avila M, Schwartz J, Téllez-Rojo MM, Lamadrid-Figueroa H, Bellinger D, Hu H, Wright RO.

Environ Health Perspect. 2008 Sep;116(9):1261-6. doi: 10.1289/ehp.11233.

Supplemental Content

Support Center